Device Feasibility and Acceptability to Improve Insomnia in Cancer

Launched by MEDSTAR HEALTH RESEARCH INSTITUTE · May 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new device called VAVA, a voice-activated virtual assistant, designed to help young adult cancer survivors improve their sleep. Many young adults who have survived cancer often struggle with sleep issues, which can be very challenging for their overall health and well-being. The trial will focus on whether using VAVA to provide a type of therapy called cognitive behavioral therapy for insomnia (CBT-I) can help these individuals sleep better.

To be eligible for this trial, participants must be between 18 and 29 years old, have a history of any type of cancer, and have been experiencing ongoing sleep problems for at least three months. They also need to have access to an internet connection at home. During the trial, participants will use the VAVA device and work with it to improve their sleep patterns. This study is currently recruiting participants, and both males and females can join. If you or someone you know might be interested, this could be a great opportunity to explore a new way to tackle sleep issues after cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age between 18 and 29 years old
• • history of cancer (any type, any stage)
• • chronic sleep loss as evidence by self-report of receiving less sleep than recommended for their age by the National Sleep Foundation for \>/= 3 months
• • must have an internet router in their primary home that they have access to (can add a second router to for the system to work)
• Exclusion Criteria:
• • acute medical/psychiatric disorder requiring treatment
• • developmental or congenital disorder
• • life expectancy \<12 months.